Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel R Langlois

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical Chemistry and Laboratory Medicine|November 11, 2022
A new milestone on the road to global standardization of apolipoprotein measurementsMichel R Langlois
Clinical Chemistry and Laboratory Medicine|March 1, 2026
Optimising lipoprotein(a) tests: we are almost thereMichel R Langlois
Clinical Chemistry|September 3, 2025
Commentary on Complex Hyponatremia in a Cancer Patient with HypercholesterolemiaMichel R Langlois
European Journal of Preventive Cardiology|August 13, 2019
Investigations on the clinical utility of apolipoprotein B measurement: A research priorityMichel R Langlois
Clinical Chemistry and Laboratory Medicine|February 26, 2025
The Friedewald formula strikes backMichel R Langlois
Clinical Chemistry and Laboratory Medicine|August 2, 2012
Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testingMichel R Langlois
Clinical Chemistry and Laboratory Medicine|December 23, 2008
Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?Eline Verhoye, Michel R Langlois,
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 5, 2020
The CCA Special Issue on Cardiovascular MarkersMichel R Langlois, Päivi Laitinen
Clinical Chemistry and Laboratory Medicine|August 12, 2009
The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC)Michel R Langlois, Pierre Wallemacq
Clinical Chemistry and Laboratory Medicine|May 15, 2002
Haptoglobin polymorphism and body iron storesJoris R Delanghe, Michel R Langlois
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|November 11, 2022
A new milestone on the road to global standardization of apolipoprotein measurementsMichel R Langlois
Clinical Chemistry and Laboratory Medicine|March 1, 2026
Optimising lipoprotein(a) tests: we are almost thereMichel R Langlois
Clinical Chemistry|September 3, 2025
Commentary on Complex Hyponatremia in a Cancer Patient with HypercholesterolemiaMichel R Langlois
European Journal of Preventive Cardiology|August 13, 2019
Investigations on the clinical utility of apolipoprotein B measurement: A research priorityMichel R Langlois
Clinical Chemistry and Laboratory Medicine|February 26, 2025
The Friedewald formula strikes backMichel R Langlois
Clinical Chemistry and Laboratory Medicine|August 2, 2012
Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testingMichel R Langlois
Clinical Chemistry and Laboratory Medicine|December 23, 2008
Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?Eline Verhoye, Michel R Langlois,
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 5, 2020
The CCA Special Issue on Cardiovascular MarkersMichel R Langlois, Päivi Laitinen
Clinical Chemistry and Laboratory Medicine|August 12, 2009
The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC)Michel R Langlois, Pierre Wallemacq
Clinical Chemistry and Laboratory Medicine|May 15, 2002
Haptoglobin polymorphism and body iron storesJoris R Delanghe, Michel R Langlois
Pageof 7